• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析过程中磷酸盐质量的清除:eKT/V 匹配的常规透析与延长透析的比较。

Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.

机构信息

Clinical and Academic Unit of Nephrology, Hospital Universitário Pedro Ernesto, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.

出版信息

Am J Nephrol. 2012;36(2):121-6. doi: 10.1159/000338675. Epub 2012 Jul 7.

DOI:10.1159/000338675
PMID:22776782
Abstract

BACKGROUND AND OBJECTIVES

The control of hyperphosphatemia is an unmet need in dialysis care. Compared to conventional hemodialysis (cHD), extended hemodialysis (eHD) appears to more easily control blood phosphate levels in chronically dialyzed patients. Here, we sought to compare eKT/V-matched cHD and eHD procedures in order to quantify the contribution of dialysis prescription and time in the mass removal of phosphate.

METHODS

Eight stable hemodialysis patients with negligible residual renal function underwent cHD and eHD sessions adjusted to provide the same eKT/V(urea). Total dialysate, total and hourly partial dialysate and blood samples were collected for comparison of mass extraction of urea, creatinine, and phosphate.

RESULTS

Mean eKT/V(urea) was similar in eHD and cHD (1.30 vs. 1.28, p = nonsignificant). Likewise, mass removal of urea and creatinine during cHD and eHD were not significantly different. Conversely, phosphate mass removal was 40% higher with eHD as compared to cHD (1,219 ± 262 vs. 858 ± 186 mg, p = 0.015). Although hourly mass removal of phosphate was higher during cHD, the prolonged period of lesser but continuous removal was responsible for higher total phosphate elimination during eHD.

CONCLUSION

In dialysis sessions matched to provide a similar eKT/V(urea), removal of phosphate increases by 40% when time is extended from 4 to 8 h. Urea-based adequacy models cannot be used to predict the amount of phosphorus removal during hemodialysis.

摘要

背景与目的

控制高磷血症是透析治疗中的一个未满足的需求。与传统血液透析(cHD)相比,延长血液透析(eHD)似乎更能轻易地控制慢性透析患者的血磷水平。在此,我们旨在比较 eKT/V 匹配的 cHD 和 eHD 程序,以量化透析方案和时间对磷酸盐质量去除的贡献。

方法

8 名稳定的血液透析患者几乎没有残余肾功能,他们接受了 cHD 和 eHD 治疗,调整后的方案可提供相同的 eKT/V(尿素)。收集总透析液、总部分透析液和每小时部分透析液以及血液样本,以比较尿素、肌酐和磷酸盐的质量提取。

结果

eHD 和 cHD 的平均 eKT/V(尿素)相似(1.30 对 1.28,p=无显著性差异)。同样,cHD 和 eHD 期间尿素和肌酐的质量去除也无显著差异。相反,与 cHD 相比,eHD 时磷酸盐的质量去除增加了 40%(1,219 ± 262 对 858 ± 186 mg,p=0.015)。尽管 cHD 期间磷酸盐的每小时质量去除较高,但由于延长了时间,连续去除的时间较短,但总磷酸盐的去除量仍较高。

结论

在提供相似 eKT/V(尿素)的透析治疗中,将时间从 4 小时延长至 8 小时可使磷酸盐的去除量增加 40%。基于尿素的充分性模型不能用于预测血液透析期间磷的去除量。

相似文献

1
Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.血液透析过程中磷酸盐质量的清除:eKT/V 匹配的常规透析与延长透析的比较。
Am J Nephrol. 2012;36(2):121-6. doi: 10.1159/000338675. Epub 2012 Jul 7.
2
Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.血液透析和腹膜透析方式中的磷酸盐清除。
Blood Purif. 2010;29(2):137-44. doi: 10.1159/000245640. Epub 2010 Jan 8.
3
Phosphate removal model: an observational study of low-flux dialyzers in conventional hemodialysis therapy.磷酸盐清除模型:传统血液透析治疗中低通量透析器的观察性研究
Hemodial Int. 2012 Jul;16(3):363-76. doi: 10.1111/j.1542-4758.2012.00678.x. Epub 2012 Feb 23.
4
Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group.直接通过尿素清除率测量血液透析剂量时的不精确性。血液透析研究组。
Kidney Int. 1999 Feb;55(2):635-47. doi: 10.1046/j.1523-1755.1999.00269.x.
5
Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.超重血液透析患者采用几种每周三次透析方法进行磷清除。
Am J Kidney Dis. 2009 Dec;54(6):1108-15. doi: 10.1053/j.ajkd.2009.05.018. Epub 2009 Jul 19.
6
Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance.使用紫外线吸光度(在线)、血尿素、透析液尿素和离子透析率测量法的透析剂量(Kt/V)及清除率变化敏感性
Nephrol Dial Transplant. 2006 Aug;21(8):2225-31. doi: 10.1093/ndt/gfl147. Epub 2006 Apr 12.
7
Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.血液透析滤过——血液透析患者高磷血症的一种新治疗选择。
Clin Nephrol. 1999 Sep;52(3):152-9.
8
Accuracy of using 30-minute post-dialysis BUN to determine equilibrated Kt/V.使用透析后30分钟的尿素氮(BUN)来测定平衡Kt/V的准确性。
J Med Assoc Thai. 2006 Aug;89 Suppl 2:S54-64.
9
Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial.终末期肾病的每日血液滤过:一项可行性和疗效试验。
Blood Purif. 2004;22(6):481-9. doi: 10.1159/000081722. Epub 2004 Oct 27.
10
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound.无醋酸盐生物滤过疗程的效率和时长对透析后溶质反弹的影响。
Am J Kidney Dis. 2006 Jun;47(6):1045-54. doi: 10.1053/j.ajkd.2006.03.035.

引用本文的文献

1
The optimal exercise modality and intensity for hemodialysis patients incorporating Bayesian network meta-analysis and systematic review.纳入贝叶斯网络荟萃分析和系统评价的血液透析患者的最佳运动方式和强度
Front Physiol. 2022 Sep 19;13:945465. doi: 10.3389/fphys.2022.945465. eCollection 2022.
2
Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease.慢性肾脏病继发性甲状旁腺功能亢进症管理中的争议。
Curr Osteoporos Rep. 2019 Oct;17(5):333-342. doi: 10.1007/s11914-019-00533-x.